Tufts Center for the Study of Drug Development

CSDD News
The Tufts Center for the Study of Drug Development is an independent, academic, non-profit research group at Tufts University in Boston, Massachusetts.
Tufts University
http://twitter.com/TuftsCSDD
http://csdd.tufts.edu

413 followers

152 tweets

TuftsCSDD Check out Tufts CSDD's LinkedIn group, Clinical Study Design and Protocol Development Group, http://t.co/RJFbhJRv

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD May/Jun Impact Report released today, "User fee era in U.S. currently poses mixed regulatory burden for sponsors" - http://t.co/EyFbNFkI

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Press release: Drug Sponsors' Regulatory Experience Was Mixed During PDUFA IV, http://t.co/8bHkznG9

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Just released the April 2012 R&D Management Report, http://t.co/QD7eYxP7

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Press release: Drug Companies Are Looking to Shorten Time to Early Clinical Development, http://t.co/YthR8m3o

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Visit the Tufts CSDD website to find out how you can get your complimentary copy of the Outlook 2012, http://t.co/VvJmNsUs

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD CSDD's Janice Reichert quoted in "The Science of Biosimilars", http://t.co/oFQ9HVAG

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD CSDD's Christopher-Paul Milne quoted in "Oregon patients caught between insurers, high cost for specialty drugs, http://t.co/klGx5SGy

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Just released: Tufts CSDD Quarterly Update, Vol. 8, Issue 1, http://t.co/4FyTQSyN

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Early-bird rates available for Tufts CSDD Leadership for Drug Development Teams course, http://t.co/6Rn9Gxtm

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD New Impact Report just released: Pace of CNS drug development and FDA approvals lags other drug classes, http://t.co/zvAbUkon

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Press release: Drugs to Treat CNS Diseases Take 35% Longer to Develop than Other Drugs, http://t.co/Cs1HNjji

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Save the date for the Tufts CSDD Leadership Course For Drug Development Teams: July 10-11, 2012 in Boston, MA, http://t.co/6Rn9Gxtm

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Agenda now available for Feb. 23 roundtable, Managing the Transition from Nonclinical to Early Clinical Development, http://t.co/P0dca5qR

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Learn strategies for transitioning from nonclinical to clinical drug development on Feb23rd! http://t.co/PmEfYp4Q #TuftsCSDDExecutiveForum

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Learn more about early clinical risk mitigation strategies at Tufts CSDD! http://t.co/PmEfYp4Q #TuftsCSDDExecutiveForum #Feb23Roundtable

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Now posted! Some speakers for the #Feb23Roundtable #TuftsCSDDExecutiveForum on the transition to clinical development http://t.co/PmEfYp4Q

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Sign up for the Feb. 23rd roundtable, "Managing the Transition from Nonclinical to Early Clinical Development" - http://t.co/P0dca5qR

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Pharma and biotech clinops colleagues, still time to take part in a #TuftsCSDD study on budget and planning practices , http://t.co/tidbvLVd

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Purchase the new R&D Management Report "Resource Management Strategies to Optimize R&D Performance" - http://t.co/Kr3EsMfW

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Press release for Jan. R&D Mgmt Report: Drug Company Executives Are Expanding Their Use of Strategic Partnerships, http://t.co/kpGwlDOp

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Outsourcing-Pharma.com - CRAs spend less than half their time in on-site monitoring tasks, says [TuftsCSDD]: http://t.co/osNioFh3

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Only one week left to register for the 2012 Tufts Postgraduate Course, don't miss out: http://t.co/9bJfH4QO

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Pharma and biotech clinops colleagues, participate in a #TuftsCSDD study on budget and planning practices , http://t.co/Qxqa8VK8

by Tufts Center for the Study of Drug Development, CSDD News, Tufts University

TuftsCSDD Time is running out to register for the Tufts Postgraduate Course, Feb. 6-10, 2012: http://t.co/9bJfH4QO